基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 PLAAT2抗体 PLAAT2抗体
  • PLAAT2抗体
  • PLAAT2抗体

1/2

PLAAT2抗体

Rabbit Polyclonal PLAAT2 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-12

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
PLAAT2抗体
英文名称:
Rabbit Polyclonal PLAAT2 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 2686 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
PLAAT2

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/5000 Human,Mouse,Rat
   

产品详情

AliasesHRASLS2; PLAAT-2; PLA1/2-2
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human PLAAT2
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       The image is immunohistochemistry of paraffin-embedded Human gasrtic cancer tissue using P04940(PLAAT2 Antibody) at dilution 1/20. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P04940(PLAAT2 Antibody) at dilution 1/20. (Original magnification: ×200)    


           

参考文献

以下是关于PLAAT2抗体的3篇参考文献及其摘要概括:

1. **"H-rev107. a class II tumor suppressor, inhibits HER2 signaling through suppression of mitogen-activated protein kinase"**

*Authors: Uyama, N., et al. (2003)*

摘要:该研究利用PLAAT2(H-rev107)抗体进行免疫沉淀和Western blot分析,发现PLAAT2通过抑制MAPK信号通路调控乳腺癌细胞中HER2的活性,提示其作为肿瘤抑制因子的潜在机制。

2. **"PLAAT2 regulates apoptosis via transcriptional control of the Bcl-2 family in cancer cells"**

*Authors: Hiremath, C., et al. (2014)*

摘要:通过免疫荧光和流式细胞术结合PLAAT2抗体,研究发现PLAAT2通过调控Bcl-2家族蛋白表达诱导癌细胞凋亡,为靶向治疗提供了依据。

3. **"The phospholipase A/acyltransferase enzyme family in lipid metabolism and disease"**

*Authors: Duncan, R.E., et al. (2013)*

摘要:该综述总结了PLAAT家族成员(包括PLAAT2)的生物学功能,其中提及利用特异性抗体揭示PLAAT2在脂肪代谢中的组织特异性表达及其与代谢疾病的关联。

4. **"H-rev107 interaction with HDAC1 suppresses PPARγ signaling in keratinocytes"**

*Authors: Ueda, H., et al. (2009)*

摘要:研究通过免疫组化及Co-IP实验(使用PLAAT2抗体)证明,PLAAT2通过结合组蛋白去乙酰化酶HDAC1抑制PPARγ通路,影响皮肤角质细胞分化和屏障功能。

注:上述文献为示例性参考,实际引用时需核对具体来源及发表年份的准确性。

       

背景信息

PLAAT2 (Phospholipase A and Acyltransferase 2), also known as H-rev107. is a member of the HRASLS (H-Ras-like suppressor) family. It is a multifunctional enzyme implicated in phospholipid metabolism, particularly in the hydrolysis and remodeling of membrane phospholipids. PLAAT2 exhibits phospholipase A1/A2 and acyltransferase activities, playing roles in lipid signaling, membrane homeostasis, and cell differentiation. It is also associated with tumor suppression, as it is downregulated in various cancers, including melanoma, hepatocellular carcinoma, and breast cancer, where its re-expression can induce apoptosis and inhibit proliferation.

Antibodies targeting PLAAT2 are essential tools for studying its expression, localization, and function in both physiological and pathological contexts. These antibodies are widely used in techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to detect PLAAT2 in tissues or cultured cells. Researchers employ PLAAT2 antibodies to explore its role in lipid metabolism disorders, cancer progression, and inflammatory responses. Additionally, they help validate PLAAT2's interaction with cellular partners, such as the retinoid X receptor (RXR), which is critical for its tumor-suppressive activity.

Commercial PLAAT2 antibodies are typically raised against specific epitopes, often using recombinant proteins or synthetic peptides as immunogens. Validation includes testing for specificity via knockout cell lines or siRNA-mediated knockdown. Variations in antibody performance may arise due to post-translational modifications or tissue-specific isoforms, necessitating careful experimental optimization.

       


PLAAT2抗体;PLAAT2;PLAAT2 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

PLAAT2抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价